Salinomycin, a potential cancer-fighting medication, triggered cell death by generating reactive oxygen species (ROS), and this process was associated with ROS-driven autophagy by controlling the PI3K/Akt/mTOR and ERK/p38 MAPK signaling pathways. The gene discussed is AKT1; the disease is cancer.